N-(4-氯苯基)-2-氧代甘氨酸乙酯 | 5397-14-8

• 物质功能分类: 生物化工 - 氨基酸及其衍生物 - 甘氨酸类衍生物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: N-(4-氯苯基)-2-氧代甘氨酸乙酯
• 中文别名: 2-((4-氯苯基)氨基)-2-氧代乙酸乙酯
• 英文名称: ethyl 2-[(4-chlorophenyl)amino]-2-oxoacetate
• 英文别名: ethyl 4'-chlorooxanilate；ethyl N-(4-chlorophenyl)oxamate；N-(p-Chlor-phenyl)-oxaminsaeureaethylester；Ethyl [(4-chlorophenyl)amino](oxo)acetate；ethyl 2-(4-chloroanilino)-2-oxoacetate
• CAS: 5397-14-8
• 化学式: C₁₀H₁₀ClNO₃
• mdl: MFCD00000611
• 分子量: 227.647
• InChiKey: JFAOXNRPSKOLNC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  55.4
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2924299090

反应信息

• 作为反应物：
  描述：

  N-(4-氯苯基)-2-氧代甘氨酸乙酯 在 水 、 O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 、 三乙胺 、 sodium hydroxide 作用下， 以 乙醇 为溶剂， 生成 N¹-(4-chlorophenyl)-N²-((5-(2-hydroxyethyl)-4-methylthiazol-2-yl)(piperidin-2-yl)methyl)oxalamide formate
  参考文献：
  名称：

  Design, Synthesis, and Antiviral Activity of Entry Inhibitors That Target the CD4-Binding Site of HIV-1

  摘要：

  The CD4 binding site on HIV-1 gp120 has been validated as a drug target to prevent HIV-1 entry to cells. Previously, we identified two small molecule inhibitors consisting of a 2,2,6,6-tetramethylpiperidine ring linked by an oxalamide to a p-halide-substituted phenyl group, which target this site, specifically, a cavity termed "Phe43 cavity". Here we use synthetic chemistry, functional assessment, and structure-based analysis to explore variants of each region of these inhibitors for improved antiviral properties. Alterations of the phenyl group and of the oxalamide linker indicated that these regions were close to optimal in the original lead compounds. Design of a series of compounds, where the tetramethylpiperidine ring was replaced with new scaffolds, led to improved antiviral activity. These new scaffolds provide insight into the surface chemistry at the entrance of the cavity and offer additional opportunities by which to optimize further these potential-next-generation therapeutics and microbicides against HIV-1.

  DOI：

  10.1021/jm3002247
• 作为产物：
  描述：

  N-(p-Chlorphenyl)-aminofumarsaeureethylester 在 叔丁基过氧化氢 作用下， 以 水 、 氯苯 为溶剂， 反应 2.0h， 以80%的产率得到N-(4-氯苯基)-2-氧代甘氨酸乙酯
  参考文献：
  名称：

  叔丁基过氧化氢促进缺电子烯胺的无金属氧化 C=C 键裂解

  摘要：

  描述了一种新型的叔丁基氢过氧化物 (TBHP) 促进的烯胺氧化 C=C 双键裂解。在 TBHP 存在下，将缺电子烯胺的氯苯溶液在 80°C 下加热两小时，导致 C=C 键断裂。本研究为利用 TBHP 形成 C=O 双键提供了一种新策略。

  DOI：

  10.1055/s-0036-1588990

文献信息

• Diamine derivatives
  申请人：Ohta Toshiharu

  公开号：US20050020645A1

  公开（公告）日：2005-01-27

  A compound represented by the general formula (1): Q 1 -Q 2 -T 0 -N(R 1 )-Q 3 -N(R 2 )-T 1 -Q 4 (1) wherein R 1 and R 2 are hydrogen atoms or the like; Q 1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q 2 is a single bond or the like; Q 3 is a group in which Q 5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T 0 and T 1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.

  通用式（1）表示的化合物： Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4（1） 其中R1和R2是氢原子或类似物；Q1是饱和或不饱和的、5-或6-成员环烃基，可以被取代，或类似物；Q2是单键或类似物；Q3是一个基团，其中Q5是具有1至8个碳原子的烷基基团，或类似物；T0和T1是羰基团或类似物；其盐、溶剂合物或N-氧化物。 该化合物可用作预防和/或治疗脑梗死、脑栓塞、心肌梗死、心绞痛、肺梗死、肺栓塞、布尔格病、深静脉血栓形成、弥散性血管内凝血综合征、瓣膜或关节置换后的血栓形成、血管成形术后的血栓形成和再闭塞、全身性炎症反应综合征（SIRS）、多器官功能障碍综合征（MODS）、体外循环期间的血栓形成，或抽血时的血液凝结。
• Design, synthesis and SAR of a novel series of heterocyclic phenylpropanoic acids as GPR120 agonists
  作者：Xuqing Zhang、Chaozhong Cai、Michael Winters、Michele Wells、Mark Wall、James Lanter、Zhihua Sui、Jingyuan Ma、Aaron Novack、Imad Nashashibi、Yuanping Wang、Wen Yan、Arthur Suckow、Hong Hua、Austin Bell、Peter Haug、Wilma Clapper、Celia Jenkinson、Joseph Gunnet、James Leonard、William V. Murray

  DOI：10.1016/j.bmcl.2017.06.028

  日期：2017.8

  A novel series of 5-membered heterocycle-containing phenylpropanoic acid derivatives was discovered as potent GPR120 agonists with low clearance, high oral bioavailability and in vivo antidiabetic activity in rodents.

  发现了一系列新型的五元含杂环苯丙酸衍生物，作为强效的GPR120激动剂，在啮齿类动物中具有低清除率，高口服生物利用度和体内抗糖尿病活性。
• New Highlights in the Synthesis of 4-Aryl-1,4-dihydropyrazines
  作者：Jing-Yu He、Xiu-Qing Song、Hong Yan、Ru-Gang Zhong

  DOI：10.1002/jhet.989

  日期：2012.11

  The 4‐aryl‐1,4‐dihydropyrazines were prepared via the cyclization of N,N‐bisalkylated anilines with ammonium acetate. These reactions were aided by improvements in the synthesis of N,N‐bisalkylated anilines which were alkylated with anilines using ethyl 2‐diazo acetoacetate in a reaction catalyzed by rhodium acetate in the absence of oxygen. A possible mechanistic route is postulated on the basis of

  通过将N，N-双烷基化苯胺与乙酸铵环化来制备4-芳基-1,4-二氢吡嗪。这些反应得益于N，N-双烷基化苯胺的合成的改进，N2-N-双烷基化苯胺在无氧乙酸铑的催化下，使用乙酰丙酮-2-重氮乙酯与苯胺烷基化。推测可能的机理路线是基于N烷基化中间体的分离，该中间体经1 H NMR数据和X射线衍射确定为N芳基草酸酯。
• Discovery of Cytochrome P450 4F11 Activated Inhibitors of Stearoyl Coenzyme A Desaturase
  作者：Sarah E. Winterton、Emanuela Capota、Xiaoyu Wang、Hong Chen、Prema L. Mallipeddi、Noelle S. Williams、Bruce A. Posner、Deepak Nijhawan、Joseph M. Ready

  DOI：10.1021/acs.jmedchem.8b00052

  日期：2018.6.28

  Stearoyl-CoA desaturase (SCD) catalyzes the first step in the conversion of saturated fatty acids to unsaturated fatty acids. Unsaturated fatty acids are required for membrane integrity and for cell proliferation. For these reasons, inhibitors of SCD represent potential treatments for cancer. However, systemically active SCD inhibitors result in skin toxicity, which presents an obstacle to their development

  硬脂酰辅酶A去饱和酶（SCD）催化饱和脂肪酸向不饱和脂肪酸转化的第一步。膜完整性和细胞增殖需要不饱和脂肪酸。由于这些原因，SCD抑制剂代表了潜在的癌症治疗方法。但是，具有内在活性的SCD抑制剂会导致皮肤毒性，这对它们的发展构成了障碍。我们最近描述了一系列草酸二酰胺，它们通过CYP4F11介导的代谢转化为癌症子集内的活性SCD抑制剂。在本文中，我们描述了草酸二酰胺和相关N-酰基脲的优化，以及与代谢活化和SCD抑制有关的结构-活性关系的分析。
• Visible light-mediated photocatalytic oxidative cleavage of activated alkynes <i>via</i> hydroamination: a direct approach to oxamates
  作者：Narenderreddy Katta、Mamata Ojha、Arumugavel Murugan、Sagar Arepally、Duddu S. Sharada

  DOI：10.1039/c9ra10555g

  日期：——

  The direct oxidative cleavage of activated alkynes via hydroamination has been described using organic photocatalyst under visible-light irradiation at room temperature. In this reaction, the single electron oxidation of an in situ formed enamine followed by radical coupling with an oxidant finally delivers the oxamate. The key features of this photocatalytic reaction are the mild reaction conditions

  已经描述了在室温下在可见光照射下使用有机光催化剂通过加氢胺化直接氧化裂解活化的炔烃。在该反应中，原位形成的烯胺的单电子氧化，然后与氧化剂自由基偶联，最终得到草酸盐。该光催化反应的主要特点是反应条件温和，无金属有机染料作为光催化剂，TBHP作为“O”源和光催化剂再生的双重作用。

表征谱图